We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Apple
AAPL
$4.54T
| $463K | 0.01% |
16,804
-336,824
| -95% | -$9.88M |
|
577
First Solar
FSLR
$22.7B
| $462K | 0.01% |
10,801
+4,061
| +60% | +$188K |
|
|
EQY
578
DELISTED
Equity One
EQY
| $460K | 0.01% |
+18,882
| New | +$460K |
|
579
Sysco
SYY
$40.8B
| $459K | 0.01% |
11,786
-18,293
| -61% | -$698K |
|
|
TCO
580
DELISTED
Taubman Centers Inc.
TCO
| $456K | 0.01% |
+6,599
| New | +$468K |
|
581
Cirrus Logic
CRUS
$6.53B
| $455K | 0.01% |
14,434
+1,188
| +9% | +$36.4K |
|
|
DOC
582
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $453K | 0.01% |
+30,000
| New | +$461K |
|
583
Urban Edge Properties
UE
$2.86B
| $452K | 0.01% |
+20,924
| New | +$447K |
|
584
AGNC Investment
AGNC
$12.4B
| $451K | 0.01% |
24,125
-4,026
| -14% | -$77.3K |
|
|
JOYY
585
JOYY Inc
JOYY
$3.71B
| $451K | 0.01% |
+8,260
| New | +$477K |
|
586
Babcock & Wilcox
BW
$1.39B
| $442K | 0.01% |
+2,629
| New | +$485K |
|
587
SLM Corp
SLM
$4.89B
| $438K | 0.01% |
59,187
+4,716
| +9% | +$41.6K |
|
588
Hain Celestial
HAIN
$45M
| $432K | 0.01% |
+8,366
| New | +$530K |
|
589
Sony
SONY
$137B
| $427K | 0.01% |
+87,250
| New | +$465K |
|
|
NAV
590
DELISTED
Navistar International
NAV
| $426K | 0.01% |
33,485
+6,490
| +24% | +$114K |
|
|
PIR
591
DELISTED
Pier 1 Imports, Inc.
PIR
| $421K | 0.01% |
+3,047
| New | +$665K |
|
592
MGIC Investment
MTG
$6.16B
| $419K | 0.01% |
+45,219
| New | +$479K |
|
593
SEI Investments
SEIC
$12.4B
| $417K | 0.01% |
+8,654
| New | +$441K |
|
|
ACAS
594
DELISTED
American Capital Ltd
ACAS
| $416K | 0.01% |
34,232
+17,130
| +100% | +$230K |
|
595
Constellation Brands
STZ
$22.2B
| $415K | 0.01% |
3,317
-86,095
| -96% | -$10.6M |
|
|
NSM
596
DELISTED
Nationstar Mortgage Holdings
NSM
| $415K | 0.01% |
+29,916
| New | +$502K |
|
597
Allison Transmission
ALSN
$9.5B
| $413K | 0.01% |
15,472
-8,428
| -35% | -$241K |
|
|
GGP
598
DELISTED
GGP Inc.
GGP
| $407K | 0.01% |
15,662
+6,918
| +79% | +$182K |
|
|
STJ
599
DELISTED
St Jude Medical
STJ
| $407K | 0.01% |
+6,444
| New | +$460K |
|
600
Lincoln Electric
LECO
$14.2B
| $405K | 0.01% |
7,724
-2,850
| -27% | -$167K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.